# FDA Inspection 1236667 - FXM Clinical Research Miramar, LLC. - April 05, 2024

Source: https://www.keypedia.com/records/fda_inspections/fxm-clinical-research-miramar-llc/0032da1d-018e-454a-ba9c-a84494a3d3a0
Source feed: FDA_Inspections

> FDA Inspection 1236667 for FXM Clinical Research Miramar, LLC. on April 05, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236667
- Company Name: FXM Clinical Research Miramar, LLC.
- Inspection Date: 2024-04-05
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1112542 - 2019-11-21](https://www.keypedia.com/records/fda_inspections/fxm-clinical-research-miramar-llc/d94d394f-6ed5-4b89-ab3a-caae5a730f98)
- [FDA Inspection 1069147 - 2018-09-10](https://www.keypedia.com/records/fda_inspections/fxm-clinical-research-miramar-llc/42292de4-8cc2-4196-9b9a-c69cd7e958b4)

Company: https://www.keypedia.com/companies/fxm-clinical-research-miramar-llc/ceeb76ac-06cd-4be5-a244-7b864e6f91ff

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c